                         SEQUENCE LISTING

<110>  BIOHAVEN THERAPEUTICS LTD
 
<120>  AGENTS FOR DIRECTED CONJUGATION TECHNIQUES AND CONJUGATED 
       PRODUCTS

<130>  BHL0032PCT

<150>  63/189522
<151>  2021-05-17

<160>  9     

<170>  PatentIn version 3.5

<210>  1
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  1

Gly Ser Tyr Trp Tyr Asp Val Trp Phe 
1               5                   


<210>  2
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  Disulfid
<222>  (2)..(12)

<220>
<221>  SITE
<222>  (5)..(5)
<223>  X is any amino acid

<400>  2

Asp Cys Ala Trp Xaa Leu Gly Glu Leu Val Trp Cys Thr 
1               5                   10              


<210>  3
<211>  56
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  acetylation
<222>  (1)..(1)
<223>  N-terminal

<220>
<221>  non_ter
<222>  (56)..(56)

<400>  3

Asp Lys Glu Trp Ile Leu Gln Lys Ile Tyr Glu Ile Met Arg Leu Leu 
1               5                   10                  15      


Asp Glu Leu Gly His Ala Glu Ala Ser Met Arg Val Ser Asp Leu Ile 
            20                  25                  30          


Tyr Glu Phe Met Lys Lys Gly Asp Glu Arg Leu Leu Glu Glu Ala Glu 
        35                  40                  45              


Arg Leu Leu Glu Glu Val Glu Arg 
    50                  55      


<210>  4
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  acetylation
<222>  (1)..(1)

<220>
<221>  disulfid
<222>  (2)..(12)

<400>  4

Asp Cys Ala Trp Asn Leu Gly Glu Leu Val Trp Cys Thr 
1               5                   10              


<210>  5
<211>  13
<212>  PRT
<213>  artificial sequence

<220>
<223>  synthetic


<220>
<221>  acetylation
<222>  (1)..(1)

<220>
<221>  disulfid
<222>  (2)..(12)

<220>
<221>  non_ter
<222>  (13)..(13)

<400>  5

Asp Cys Ala Trp His Leu Gly Glu Leu Val Trp Cys Thr 
1               5                   10              


<210>  6
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  non_ter
<222>  (1)..(1)

<220>
<221>  disulfid
<222>  (2)..(12)

<400>  6

Asp Cys Ala Trp His Leu Gly Glu Leu Val Trp Cys Thr 
1               5                   10              


<210>  7
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  SITE
<222>  (11)..(11)
<223>  X is Tic

<220>
<221>  SITE
<222>  (12)..(12)
<223>  X is Aib

<220>
<221>  Non_term
<222>  (14)..(14)

<400>  7

Ala Ser Tyr His Leu Gly Glu Leu Val Trp Xaa Xaa Cys Glu 
1               5                   10                  


<210>  8
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  disulfid
<222>  (2)..(12)

<400>  8

Asp Cys Ala Trp His Leu Gly Glu Leu Val Trp Cys Thr 
1               5                   10              


<210>  9
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  disulfid
<222>  (1)..(15)

<220>
<221>  disulfid
<222>  (3)..(13)

<400>  9

Cys Asp Cys Ala Trp His Leu Gly Glu Leu Val Trp Cys Thr Cys 
1               5                   10                  15  


